# A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects

> **NCT01416207** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Avonex

## Key facts

- **NCT ID:** NCT01416207
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416207, "A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01416207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*